Last update:

Inflammatory disorders news

Immunology

FDA approves Benlysta autoinjector for pediatric patients with active lupus nephritis

The U.S. Food and Drug Administration has approved GSK's autoinjector of Benlysta (belimumab) for subcutaneous injection in patients ≥5 years of age with active lupus nephritis who are receiving standard therapy.

Inflammatory disorders

Aging-related inflammation is not universal across human populations, new study finds

Inflammation, long considered a hallmark of aging, may not be a universal human experience, according to a new study from Columbia University Mailman School of Public Health. The research suggests that "inflammaging"—chronic, ...

Diseases, Conditions, Syndromes

FDA approves Dupixent for bullous pemphigoid

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) for the treatment of adult patients with bullous pemphigoid.

Inflammatory disorders

Why are urban children more prone to allergies?

Scientists discovered that a previously uncharacterized subset of immune cells may play a critical role in the development of allergic diseases and explain differences between urban and rural populations. The finding, published ...

Inflammatory disorders

How exercise helps prevent acute muscle pain from becoming chronic

A study conducted at the State University of Campinas (UNICAMP) in Brazil investigated the process of muscle pain chronification—that is, when it goes from acute to chronic—and identified one of the mechanisms by which ...